Log in to save to my catalogue

Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased p...

Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1350377192

Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation

About this item

Full title

Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation

Publisher

United States: Public Library of Science

Journal title

PloS one, 2013-05, Vol.8 (5), p.e63118-e63118

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The only approved pharmacological treatment for ischemic stroke is intravenous administration of plasminogen activator (tPA) to re-canalize the occluded cerebral vessel. Not only reperfusion but also tPA itself can induce an inflammatory response. Microglia are the innate immune cells of the central nervous system and the first immune cells to beco...

Alternative Titles

Full title

Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1350377192

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1350377192

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0063118

How to access this item